Rosuvastatin induced photolocalized purpura

Rosuvastatin induced photolocalized purpura

Bibliographic Details
Main Authors:	Marwa Thabouti, Nadia Gahriani Fetoui, Linda Manaa, Jacem Rouatbi, Badreddine Sriha, Chaker Ben Salem, Mohamed Denguezli
Format:	Article
Language:	English
Published:	Wiley 2022-09-01
Series:	Clinical Case Reports
Subjects:	photolocalized purpura photosensitivity rosuvastatin
Online Access:	https://doi.org/10.1002/ccr3.6375

Similar Items

A Cornflake-like Dermatitis: A Quiz
by: Marwa Thabouti, et al.
Published: (2023-03-01)

ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS
by: Nadeem Ul Haq, et al.
Published: (2019-12-01)

Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023-01-01)

The Antimycotic Activity of Rosuvastatin
by: Zahraa Qasim
Published: (2022-12-01)

Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
by: Wen Wang, et al.
Published: (2022-04-01)

The Effect of Rosuvastatin on the Liver Enzyme of NMRI Mouse
by: Atena Nehzati Asl, et al.
Published: (2022-05-01)

A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01)

Analysis of genetic aspects of therapy with Rosuvastatin
by: Samat Kozhakhmetov, et al.
Published: (2016-06-01)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
by: Parson H
Published: (2010-01-01)

Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects
by: E V Luchinina, et al.
Published: (2017-12-01)

Modern views on clinical and economical effectiveness of rosuvastatin
by: S. K. Zyryanov, et al.
Published: (2008-02-01)

The impact of rosuvastatin on inflammatory markers in L-NAME induced hypertensive rats
by: Kawa F. Dizaye, et al.
Published: (2023-04-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
by: Anikin G.S., et al.
Published: (2017-11-01)

Spectrophotometric determination of rosuvastatin in pharmaceutical formulations using quinalizarin
by: Monica Força Lima, et al.
Published: (2017-07-01)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01)

Role of rosuvastatin in bone metabolism of ovariectomized adult rats
by: Sumaya S. Salih, et al.
Published: (2023-01-01)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020-11-01)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
by: Ji Hoe Heo, et al.
Published: (2016-01-01)

Rosuvastatin as a Supplemental Treatment for the Clinical Symptoms of Nephropathia Epidemica: A Pilot Clinical Study
by: Venera Shakirova, et al.
Published: (2024-02-01)

New data on the use of rosuvastatin and acetylsalicyl acid for the prolongation of human life
by: M. V. Ezhov, et al.
Published: (2018-04-01)

Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
by: Keiki Sakurama, et al.
Published: (2023-04-01)

Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
by: M Yu Zubareva, et al.
Published: (2014-06-01)

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
by: Jure Zakrajšek, et al.
Published: (2017-12-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Cutis verticis gyrata in a 24‐year‐old young man revealing a T‐cell lymphoblastic lymphoma
by: Sarra Saad, et al.
Published: (2022-10-01)

Differential Renoprotective Actions of Simvastatin and Rosuvastatin in Streptozotocin-Induced Diabetes in Sprague-Dawley Rat
by: Rowaida Refaat, et al.
Published: (2020-06-01)

Púrpura de Henoch-Schönlein: recorrência e cronicidade Henoch-Schönlein purpura: recurrence and chronicity
by: Camila S. Alfredo, et al.
Published: (2007-04-01)

Investigation of montelukast effect on rosuvastatin induced late puberty in rats
by: Tamadir Hamid Wadi Aledani, et al.
Published: (2022-01-01)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018-10-01)

Púrpura em paciente com estrongiloidíase disseminada Purpura in patient with disseminated strongiloidiasis
by: Luciano C. Ribeiro, et al.
Published: (2005-05-01)

Experimental evaluation of the antinociceptive and anti-inflammatory effects of rosuvastatin and its interaction with celecoxib and paracetamol
by: Abdullah M. Jawad, et al.
Published: (2015-06-01)

Idiopathic thrombotic thrombocytopenic purpura
by: Carmen Garrido Arce, et al.
Published: (2009-09-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
by: V. V. Kukharchuk, et al.
Published: (2013-06-01)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
by: Lijun Wang, et al.
Published: (2018-06-01)

Oral Ecchymosis in elderly: Senile purpura
by: Srikanth H Srivathsa
Published: (2015-01-01)

USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING
by: A. T. Abdrashitova, et al.
Published: (2016-01-01)

Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment
by: Joon‐Tae Kim, et al.
Published: (2025-02-01)

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
by: Kim CH, et al.
Published: (2017-12-01)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)